JJMT Leads The Conversation On Data Governance and Innovation At MedTech Forum 2022

MedTech Forum

Johnson & Johnson MedTech (JJMT) played a central role in last week’s MedTech Forum - Europe’s largest health and medical technology conference, hosted by industry association MedTech Europe. This year’s conference took place in Barcelona - the first time in two years that the conference has been held live.​ ​

Many colleagues from JJMT attended in person, joining delegates from across the medical technology sector, Government, and academia to participate in three days of debate, discussion and expert opinion from industry leaders and influencers.​ ​

JJMT was a key sponsor of the event and also contributed a range of speakers, including Ashley McEvoy, Executive VP and WW Chairman JJMT, and Lisa Ann Hill, Managing Director Spain, to drive the debate and offer perspectives on industry trends, opportunities, and challenges.​ Ashley joined other industry leaders from Stryker and Medtronic in a CEO #nofilter session, where she commended the EMEA region for its advancements in innovation and sustainability. She also highlighted the need for better collaboration around data regulation and for greater diversity and inclusion in medtech and healthcare ecosystems to reflect diverse patient populations.​ ​

Lisa took part in the Johnson and Johnson sponsored session on “Data governance in a patient pathway” which brought together the perspectives of patients, governments, health care providers and the industry. Lisa discussed the emerging policy landscape and practices determining how health data will be treated and used in the near future.​ ​

Other J&J speakers included Peter Schröer, Vice President EMEA & Canada Regulatory Affairs, who joined the panel on the Innovative Health Initiative which aims to create an EU-wide health research and innovation ecosystem. J&J experts and functional leaders also addressed technical sessions, including Kevin Taylor, Associate Director Regulatory Affairs Digital Capabilities, who moderated the panel ‘We see fragmentation today - but the future is EUDAMED’ where Mary Gray, Associate Director EU MDR UDI, took part. Finally, Bob Durgin, Vice President Regulatory Affairs Global Policy, tackled discussions around labelling requirements.​ ​

The JJMT physical booth at the Forum welcomed many colleagues and peers, visiting to catch up in person and hear more about our evolution to Johnson & Johnson MedTech.​ ​

To learn more about MedTech Forum click here

To catch up on live sessions from the 2022 event click here